Ingolf Askevold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ingolf Askevold has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Hecker
Department of General, Visceral, Thoracic and Transplant Surgery, University Hospital Giessen, Justus-Liebig-University Giessen, Rudolf-Buchheim-Strasse 6, 35392 Giessen, Germany
6 shared publications - Martin Reichert
Department of General, Visceral, Thoracic, and Transplant Surgery, Giessen University Hospital, Justus-Liebig-University of Giessen, Giessen, Germany
6 shared publications - Matthias Hecker
Medizinische Klinik II, Universitätsklinikum Gießen und Marburg, Standort Gießen, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Justus-Liebig-Universität, Gießen, Deutschland
5 shared publications - Werner Seeger
Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC) Member of the German Center for Lung Research (DZL) Giessen Germany
5 shared publications - Christian Koch
Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, University Hospital of Giessen and Marburg, Rudolf-Buchheim-Strasse 7, 35392 Giessen, Germany
4 shared publications - Stefan Kuhnert
Department of Internal Medicine II University Hospital Giessen and Marburg, Justus‐Liebig‐University Giessen Giessen Germany
4 shared publications
Latest Publications
- Open Access
- 9 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6368
Increase in Alveolar Septal Width Is a Histological Predictor of Chronic Lung Allograft Dysfunction and Survival in Lung Transplant Recipients—A Longitudinal Study
Background: Chronic lung allograft dysfunction (CLAD) occurs in up to 50% of patients within the first five years after lung transplantation (LuTX) and represents the main complication and cause of death regarding this surgery. Alveolar septal widening in transbronchial biopsies has shown an association with acute humoral allograft rejection. We aimed to explore histological markers that could predict the development of CLAD before its clinical manifestation. Methods: We retrospectively analyzed transbronchial biopsies taken at three time points from 57 patients who underwent LuTX between February 2010 and July 2019, 26 of whom developed CLAD up to November 2022. The biopsies were analyzed by microscopic morphometry and quantitative reverse transcription PCR to identify predictors of CLAD. Results: CLAD development was associated with increased alveolar septal width (ASW) as early as the first year post-LuTX (5.46 ± 0.76 µm versus 4.59 ± 0.44 µm; p < 0.001). The ASW in later biopsy timepoints predicted survival in multivariate models (last timepoint: hazard ratio 1.885, 95% confidence interval 1.086–3.269). Collagen (COL1A1 and COL3A1) expression was significantly increased in samples from patients who developed CLAD compared with those who did not. The increase in ASW was paralleled by interstitial deposition of COL1A1 and COL3A1 and a decrease in both the carbon monoxide (DLCO) diffusing capacity of the lung and the DLCO/alveolar volume. Conclusions: We report a new histologic approach for early assessment of risk of CLAD in patients who have undergone LuTX. The ASW represents a pre-symptomatic, continuous, and widely distributed change within the lung parenchyma that is accessible to transbronchial biopsy.
- 9 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6368
Open AccessIncrease in Alveolar Septal Width Is a Histological Predictor of Chronic Lung Allograft Dysfunction and Survival in Lung Transplant Recipients—A Longitudinal Study
Background: Chronic lung allograft dysfunction (CLAD) occurs in up to 50% of patients within the first five years after lung transplantation (LuTX) and represents the main complication and cause of death regarding this surgery. Alveolar septal widening in transbronchial biopsies has shown an association with acute humoral allograft rejection. We aimed to explore histological markers that could predict the development of CLAD before its clinical manifestation. Methods: We retrospectively analyzed transbronchial biopsies taken at three time points from 57 patients who underwent LuTX between February 2010 and July 2019, 26 of whom developed CLAD up to November 2022. The biopsies were analyzed by microscopic morphometry and quantitative reverse transcription PCR to identify predictors of CLAD. Results: CLAD development was associated with increased alveolar septal width (ASW) as early as the first year post-LuTX (5.46 ± 0.76 µm versus 4.59 ± 0.44 µm; p < 0.001). The ASW in later biopsy timepoints predicted survival in multivariate models (last timepoint: hazard ratio 1.885, 95% confidence interval 1.086–3.269). Collagen (COL1A1 and COL3A1) expression was significantly increased in samples from patients who developed CLAD compared with those who did not. The increase in ASW was paralleled by interstitial deposition of COL1A1 and COL3A1 and a decrease in both the carbon monoxide (DLCO) diffusing capacity of the lung and the DLCO/alveolar volume. Conclusions: We report a new histologic approach for early assessment of risk of CLAD in patients who have undergone LuTX. The ASW represents a pre-symptomatic, continuous, and widely distributed change within the lung parenchyma that is accessible to transbronchial biopsy.
- 26 March 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (4) , e70137
Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
Background: Chronic lung allograft dysfunction (CLAD) after lung transplantation is a common complication with a poor prognosis. We assessed the utility of quantitative computed tomography (CT) for the diagnosis, prediction, and discrimination of CLAD phenotypes.Methods: We retrospectively analyzed routine inspiratory and expiratory CT scans from 78 patients at different time points after lung transplantation. Mean lung density (MLD), parametric response mapping (PRM), percentage of air trapping, and airway wall morphology parameters were calculated using the image processing software YACTA. Diagnostic and predictive utility was determined by receiver operating characteristic analysis and Pearson correlation.Results: Markers of air trapping showed promise for the diagnosis and prediction of bronchiolitis obliterans syndrome (BOS); for example, expiratory MLD showed areas under the curve (AUCs) of 0.905 for diagnosis and 0.729 for 1‐year prediction. For diagnosis of CLAD with mixed phenotype, peripheral measurements (e.g., PRM of peripheral functional small airway disease: AUC 0.893) were most suitable. Markers of airway thickening (e.g., expiratory wall thickness at an inner perimeter of 10 mm: AUC 0.767) gave good diagnostic values for the undefined phenotype. CT biomarkers differed significantly among CLAD phenotypes.Conclusions: Different CT biomarkers are suitable for the diagnosis of CLAD phenotypes, prediction of BOS, and differentiation of CLAD phenotypes.
- 26 March 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (4) , e70137
Automated CT Image Processing for the Diagnosis, Prediction, and Differentiation of Phenotypes in Chronic Lung Allograft Dysfunction After Lung Transplantation
Background: Chronic lung allograft dysfunction (CLAD) after lung transplantation is a common complication with a poor prognosis. We assessed the utility of quantitative computed tomography (CT) for the diagnosis, prediction, and discrimination of CLAD phenotypes.Methods: We retrospectively analyzed routine inspiratory and expiratory CT scans from 78 patients at different time points after lung transplantation. Mean lung density (MLD), parametric response mapping (PRM), percentage of air trapping, and airway wall morphology parameters were calculated using the image processing software YACTA. Diagnostic and predictive utility was determined by receiver operating characteristic analysis and Pearson correlation.Results: Markers of air trapping showed promise for the diagnosis and prediction of bronchiolitis obliterans syndrome (BOS); for example, expiratory MLD showed areas under the curve (AUCs) of 0.905 for diagnosis and 0.729 for 1‐year prediction. For diagnosis of CLAD with mixed phenotype, peripheral measurements (e.g., PRM of peripheral functional small airway disease: AUC 0.893) were most suitable. Markers of airway thickening (e.g., expiratory wall thickness at an inner perimeter of 10 mm: AUC 0.767) gave good diagnostic values for the undefined phenotype. CT biomarkers differed significantly among CLAD phenotypes.Conclusions: Different CT biomarkers are suitable for the diagnosis of CLAD phenotypes, prediction of BOS, and differentiation of CLAD phenotypes.
- Open Access
- 16 September 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (9) , e15457
Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients
Background: Post‐lung transplantation (LTx) fluid accumulation can lead to dilution of serum creatinine (SCr). We hypothesized that fluid accumulation might impact the diagnosis, staging, and outcome of posttransplant acute kidney injury (AKI).Methods: In this retrospective study, we analyzed data from 131 adult LTx patients at a single German lung center between 2005 and 2018. We assessed the occurrence of AKI within 7 days posttransplant, both before and after SCr‐adjustment for fluid balance (FB), and investigated its impact on all‐cause mortality. Transient and persistent AKIs were defined as return to baseline kidney function or continuation of AKI beyond 72 h of onset, respectively.Results: AKI was diagnosed in 58.8% of patients according to crude SCr values. When considering FB‐adjusted SCr values, AKI severity was underestimated in 20.6% of patients, that is, AKI was detected in an additional 6.9% of patients and led to AKI upstaging in 23.4% of cases. Patients initially underestimated but detected with AKI only after FB adjustment had higher mortality compared to those who did not meet AKI criteria (hazard ratio [HR] 2.98; 95% confidence interval [CI] 1.06, 8.36; p = 0.038). Persistent AKI was associated with higher mortality than transient AKI, regardless of using crude or adjusted SCr values (p < 0.05). Persistent AKI emerged as an independent risk factor for mortality (HR 2.35; 95% CI 1.29, 4.30; p = 0.005).Conclusion: Adjusting for FB and evaluating renal recovery patterns post‐AKI may enhance the sensitivity of AKI detection. This approach could help identify patients with poor prognosis and potentially improve outcomes in lung transplant recipients.Trial Registration: ClinicalTrials.gov identifier: NCT03039959, NCT03046277.
- 16 September 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (9) , e15457
Open AccessPostoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients
Background: Post‐lung transplantation (LTx) fluid accumulation can lead to dilution of serum creatinine (SCr). We hypothesized that fluid accumulation might impact the diagnosis, staging, and outcome of posttransplant acute kidney injury (AKI).Methods: In this retrospective study, we analyzed data from 131 adult LTx patients at a single German lung center between 2005 and 2018. We assessed the occurrence of AKI within 7 days posttransplant, both before and after SCr‐adjustment for fluid balance (FB), and investigated its impact on all‐cause mortality. Transient and persistent AKIs were defined as return to baseline kidney function or continuation of AKI beyond 72 h of onset, respectively.Results: AKI was diagnosed in 58.8% of patients according to crude SCr values. When considering FB‐adjusted SCr values, AKI severity was underestimated in 20.6% of patients, that is, AKI was detected in an additional 6.9% of patients and led to AKI upstaging in 23.4% of cases. Patients initially underestimated but detected with AKI only after FB adjustment had higher mortality compared to those who did not meet AKI criteria (hazard ratio [HR] 2.98; 95% confidence interval [CI] 1.06, 8.36; p = 0.038). Persistent AKI was associated with higher mortality than transient AKI, regardless of using crude or adjusted SCr values (p < 0.05). Persistent AKI emerged as an independent risk factor for mortality (HR 2.35; 95% CI 1.29, 4.30; p = 0.005).Conclusion: Adjusting for FB and evaluating renal recovery patterns post‐AKI may enhance the sensitivity of AKI detection. This approach could help identify patients with poor prognosis and potentially improve outcomes in lung transplant recipients.Trial Registration: ClinicalTrials.gov identifier: NCT03039959, NCT03046277.
- Open Access
- 22 August 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e001916
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancer
Background Cancer is one of the leading causes of death worldwide, and cardiopulmonary comorbidities may further adversely affect cancer prognosis. We recently described lung cancer-associated pulmonary hypertension (PH) as a new form of PH and comorbidity of lung cancer. While patients with lung cancer with PH had significantly reduced overall survival compared with patients without PH, the prevalence and impact of PH in other cancers remain unclear. Methods In this retrospective, observational cohort study, we analysed the prevalence and impact of PH on clinical outcomes in 1184 patients with solid tumours other than lung cancer, that is, colorectal, head and neck, urological, breast or central nervous system tumours, using surrogate markers for PH determined by CT. Results PH prevalence in this cohort was 10.98%. A Cox proportional hazard model revealed a significant reduction in the median survival time of patients with cancer with PH (837 vs 2074 days; pConclusions In this study, fewer patients with cancer had surrogate parameters for PH compared with previously published results among patients with lung cancer. Consequently, the prevalence of PH in other cancers might be lower compared with lung cancer; however, PH still has a negative impact on prognosis. Furthermore, our data does not provide evidence that lung metastases cause PH. Thus, our results support the idea that lung cancer-associated PH represents a new category of PH. Our results also highlight the importance of further studies in the field of cardio-oncology.
- 22 August 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e001916
Open AccessNon-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancer
Background Cancer is one of the leading causes of death worldwide, and cardiopulmonary comorbidities may further adversely affect cancer prognosis. We recently described lung cancer-associated pulmonary hypertension (PH) as a new form of PH and comorbidity of lung cancer. While patients with lung cancer with PH had significantly reduced overall survival compared with patients without PH, the prevalence and impact of PH in other cancers remain unclear. Methods In this retrospective, observational cohort study, we analysed the prevalence and impact of PH on clinical outcomes in 1184 patients with solid tumours other than lung cancer, that is, colorectal, head and neck, urological, breast or central nervous system tumours, using surrogate markers for PH determined by CT. Results PH prevalence in this cohort was 10.98%. A Cox proportional hazard model revealed a significant reduction in the median survival time of patients with cancer with PH (837 vs 2074 days; pConclusions In this study, fewer patients with cancer had surrogate parameters for PH compared with previously published results among patients with lung cancer. Consequently, the prevalence of PH in other cancers might be lower compared with lung cancer; however, PH still has a negative impact on prognosis. Furthermore, our data does not provide evidence that lung metastases cause PH. Thus, our results support the idea that lung cancer-associated PH represents a new category of PH. Our results also highlight the importance of further studies in the field of cardio-oncology.
- Open Access
- 10 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (16) , 5219
New Perianal Sepsis Risk Score Predicts Outcome of Elderly Patients with Perianal Abscesses
Antibiotic therapy following surgical perianal abscess drainage is debated, but may be necessary for high-risk patients. Frailty has been shown to increase the risk of unfavorable outcomes in elderly surgical patients. This study aims to identify high-risk patients by retrospectively analyzing a single-center cohort and using a pretherapeutic score to predict the need for postoperative antibiotics and extended nursing care following perianal abscess drainage surgery. The perianal sepsis risk score was developed through univariable and multivariable analysis. Internal validation was assessed using the area under receiver-operating characteristic curve. Elderly, especially frail patients exhibited more severe perianal disease, higher frequency of antibiotic therapy, longer hospitalization, poorer clinical outcomes. Multivariable analysis revealed that scores in the 5-item modified frailty index, severity of local infection, and preoperative laboratory markers of infection independently predicted the need for prolonged hospitalization and anti-infective therapy after abscess drainage surgery. These factors were combined into the perianal sepsis risk score, which demonstrated better predictive accuracy for prolonged hospitalization and antibiotic therapy compared with chronological age or frailty status alone. Geriatric assessments are becoming increasingly important in clinical practice. The perianal sepsis risk score identifies high-risk patients before surgery, enabling early initiation of antibiotic therapy and allocation of additional nursing resources.
- 10 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (16) , 5219
Open AccessNew Perianal Sepsis Risk Score Predicts Outcome of Elderly Patients with Perianal Abscesses
Antibiotic therapy following surgical perianal abscess drainage is debated, but may be necessary for high-risk patients. Frailty has been shown to increase the risk of unfavorable outcomes in elderly surgical patients. This study aims to identify high-risk patients by retrospectively analyzing a single-center cohort and using a pretherapeutic score to predict the need for postoperative antibiotics and extended nursing care following perianal abscess drainage surgery. The perianal sepsis risk score was developed through univariable and multivariable analysis. Internal validation was assessed using the area under receiver-operating characteristic curve. Elderly, especially frail patients exhibited more severe perianal disease, higher frequency of antibiotic therapy, longer hospitalization, poorer clinical outcomes. Multivariable analysis revealed that scores in the 5-item modified frailty index, severity of local infection, and preoperative laboratory markers of infection independently predicted the need for prolonged hospitalization and anti-infective therapy after abscess drainage surgery. These factors were combined into the perianal sepsis risk score, which demonstrated better predictive accuracy for prolonged hospitalization and antibiotic therapy compared with chronological age or frailty status alone. Geriatric assessments are becoming increasingly important in clinical practice. The perianal sepsis risk score identifies high-risk patients before surgery, enabling early initiation of antibiotic therapy and allocation of additional nursing resources.
- Open Access
- 16 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (14) , 4142
Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients
Chronic Lung Allograft Dysfunction (CLAD) is a life-threatening complication that limits the long-term survival of lung transplantation patients. Early diagnosis remains the basis of efficient management of CLAD, making the need for distinctive biomarkers critical. This explorative study aimed to investigate the predictive power of mitochondrial DNA (mtDNA) derived from bronchoalveolar lavages (BAL) to detect CLAD. The study included 106 lung transplant recipients and analyzed 286 BAL samples for cell count, cell differentiation, and inflammatory and mitochondrial biomarkers, including mtDNA. A receiver operating curve analysis of mtDNA levels was used to assess its ability to detect CLAD. The results revealed a discriminatory pro-inflammatory cytokine profile in the BAL fluid of CLAD patients. The concentration of mtDNA increased in step with each CLAD stage, reaching its highest concentration in stage 4, and correlated significantly with decreasing FEV1. The receiver operating curve analysis of mtDNA in BAL revealed a moderate prediction of CLAD when all stages were grouped together (AUROC 0.75, p-value < 0.0001). This study has found the concentration mtDNA in BAL to be a potential predictor for the early detection of CLAD and the differentiation of different CLAD stages, independent of the underlying pathology.
- 16 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (14) , 4142
Open AccessChronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients
Chronic Lung Allograft Dysfunction (CLAD) is a life-threatening complication that limits the long-term survival of lung transplantation patients. Early diagnosis remains the basis of efficient management of CLAD, making the need for distinctive biomarkers critical. This explorative study aimed to investigate the predictive power of mitochondrial DNA (mtDNA) derived from bronchoalveolar lavages (BAL) to detect CLAD. The study included 106 lung transplant recipients and analyzed 286 BAL samples for cell count, cell differentiation, and inflammatory and mitochondrial biomarkers, including mtDNA. A receiver operating curve analysis of mtDNA levels was used to assess its ability to detect CLAD. The results revealed a discriminatory pro-inflammatory cytokine profile in the BAL fluid of CLAD patients. The concentration of mtDNA increased in step with each CLAD stage, reaching its highest concentration in stage 4, and correlated significantly with decreasing FEV1. The receiver operating curve analysis of mtDNA in BAL revealed a moderate prediction of CLAD when all stages were grouped together (AUROC 0.75, p-value < 0.0001). This study has found the concentration mtDNA in BAL to be a potential predictor for the early detection of CLAD and the differentiation of different CLAD stages, independent of the underlying pathology.
- Open Access
- 17 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1896
Early Respiratory Impairment and Pneumonia after Hybrid Laparoscopically Assisted Esophagectomy—A Comparison with the Open Approach
Patients undergoing esophageal cancer surgery are at high risk of developing severe pulmonary complications. Beneficial effects of minimally invasive esophagectomy had been discussed recently, but the incidence of perioperative respiratory impairment remains unclear. This is a retrospective single-center cohort study of patients, who underwent open (OE) or laparoscopically assisted, hybrid minimally invasive abdomino-thoracic esophagectomy (LAE) for cancer regarding respiratory impairment (PaO2/FiO2 ratio (P/FR) < 300 mmHg) and pneumonia. No differences were observed in the cumulative incidence of reduced P/FR between OE and LAE patients. Of note, until postoperative day (POD) 2, P/FR did not differ among both groups. Thereafter, the rate of patients with respiratory impairment was higher after OE on POD 3, 5, and 10 (p ≤ 0.05) and tended being higher on POD 7 and 9 (p ≤ 0.1). Although the duration of LAE procedure was slightly longer (total: p = 0.07, thoracic part: p = 0.004), the duration of surgery (Spearman’s rank correlation coefficient (rsp) = −0.267, p = 0.006), especially of laparotomy (rsp = −0.242, p = 0.01) correlated inversely with respiratory impairment on POD 3 after OE. Pneumonia occurred on POD 5 (1–25) and 8.5 (3–14) after OE and LAE, respectively, with the highest incidence after OE (p = 0.01). In conclusion, respiratory impairment and pulmonary complications occur frequently after esophagectomy. Although early respiratory impairment is independent of the surgical approach, postoperative pneumonia rate is reduced after LAE.
- 17 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1896
Open AccessEarly Respiratory Impairment and Pneumonia after Hybrid Laparoscopically Assisted Esophagectomy—A Comparison with the Open Approach
Patients undergoing esophageal cancer surgery are at high risk of developing severe pulmonary complications. Beneficial effects of minimally invasive esophagectomy had been discussed recently, but the incidence of perioperative respiratory impairment remains unclear. This is a retrospective single-center cohort study of patients, who underwent open (OE) or laparoscopically assisted, hybrid minimally invasive abdomino-thoracic esophagectomy (LAE) for cancer regarding respiratory impairment (PaO2/FiO2 ratio (P/FR) < 300 mmHg) and pneumonia. No differences were observed in the cumulative incidence of reduced P/FR between OE and LAE patients. Of note, until postoperative day (POD) 2, P/FR did not differ among both groups. Thereafter, the rate of patients with respiratory impairment was higher after OE on POD 3, 5, and 10 (p ≤ 0.05) and tended being higher on POD 7 and 9 (p ≤ 0.1). Although the duration of LAE procedure was slightly longer (total: p = 0.07, thoracic part: p = 0.004), the duration of surgery (Spearman’s rank correlation coefficient (rsp) = −0.267, p = 0.006), especially of laparotomy (rsp = −0.242, p = 0.01) correlated inversely with respiratory impairment on POD 3 after OE. Pneumonia occurred on POD 5 (1–25) and 8.5 (3–14) after OE and LAE, respectively, with the highest incidence after OE (p = 0.01). In conclusion, respiratory impairment and pulmonary complications occur frequently after esophagectomy. Although early respiratory impairment is independent of the surgical approach, postoperative pneumonia rate is reduced after LAE.